Founded in 1995
The Foundation of the American Society of Neuroradiology (Foundation) is the philanthropic arm of the American Society of Neuroradiology, a 501 (c) 3 professional society for Neuroradiologists.
Your Donations Make An Impact
The Foundation is incredibly grateful for the contributions given by our donors. These donations help fund breakthrough neuroradiology education and research and make a difference in the lives of millions of patients under the care of neuroradiologists.
Apply for a Foundation Grant Today
The Foundation of the ASNR distributes more than $920,000 each year to promote research, education, and innovation in neuroradiology via several grant and award programs.
The mission of the Foundation is to promote research, education, and innovation in neuroradiology that will advance clinical practice and improve patient outcomes.
Grant and Award Recipients
2024
Vivek Yedavalli, MD, MS
Utility of MRI Fingerprinting Arterial Spin Labeling in Detection and Characterization of Small Unruptured Arteriovenous Malformations for Treatment Planning
2024
Andreas Rauschecker, MD, PhD
Clinical Utility of AI-Enabled Quantitative Meningioma Monitoring
2024
Hosung Kim, PhD
Novel multi-modal imaging marker for regional glymphatic flow in humans as a potential early biomarker of Alzheimer’s Disease
2024
Marios Georgiadis, PhD
Quantitative Myelin Imaging In AD And Integration With Molecular Biomarkers
2024
Amy Juliano, MD
2023
Dhairya Lakhani, MD
Novel MR fingerprinting ASL in characterization of small arteriovenous malformations (AVMs)
2023
Maryam Vejdani Jahromi, MD, PhD
Machine Learning Algorithm to Detect Region of Brain Infarction based on CT Angiogram Imaging
2023
Cynthia Greene, MD, PhD
Applying pH-sensitive amide proton transfer imaging to poststroke dementia patients in order to determine imaging biomarkers of post stroke outcomes.
2023
Gabriel Broocks, MD
A multicenter study to implement an imaging biomarker for acute stroke management: deep learning-based quantification of net water uptake in the ischemic brain
2022
Alexandre Boutet, MD, MSc, PhD
Machine learning-driven individualised MR-guided Focused Ultrasound thalamotomies
Our Impact
For every $1 in Foundation grants awarded, investigators are able to secure an additional $20 in research funding from other sources.
Impact Statements
Foundation of the ASNR Grant Program – Andreas Rauschecker
I am very grateful to the ASNR Foundation for supporting my early career. This grant jumpstarted a major project to learn more about meningiomas using the latest AI tools, giving us the ability to extract imaging information from all meningiomas we have ever imaged in our healthcare system — and relating these to outcomes. At the same time, we are making radiologists more efficient by giving them quantitative data and obviating manual measurements. Based on the work that the ASNR Foundation Grant enabled, we were able to submit for a large NIH grant. Ultimately we expect this work to result in data-driven personalized health decisions for patients with brain tumors such as meningiomas.
Foundation of the ASNR Grant Program – Hosung Kim
I am incredibly grateful for this ASNR Foundation Grant, which supports our efforts to develop RAPiD (Regional Assessment of Perivascular water Diffusivity), a novel MRI-based method for assessing glymphatic function in Alzheimer’s disease (AD). By improving our ability to measure regional glymphatic flow, this research aims to identify early imaging markers of AD, paving the way for more precise diagnosis and intervention. The Foundation of the ASNR grant has provided important initial resources for me in advancing our work, including our ISMRM 2025 abstract that presents the fundamental methodology of our technique. I believe this grant will serve as a foundation for future studies translating these findings into clinical applications for improved patient outcomes.
Foundation of the ASNR Grant Program — Vivek Yedavalli
Currently, there is no treatment consensus for small unruptured intracranial arteriovenous malformations, which continues to be a challenge for our clinicians in managing patients afflicted with this disease. These small AVM patients are at risk of hemorrhage, stroke, seizures, etc, necessitating biomarkers to help with treatment planning to prevent such dire complications. Thanks to the generous support of the Foundation of ASNR, we are able to improve detection and characterization of small AVMs utilizing a novel MRI fingerprinting arterial spin labeling method. I am grateful to the Foundation for providing the support to explore the clinical translation of this unique method where our biomarkers assist with treatment planning for these AVM patients. The funding from the Foundation gives me the time and opportunity to enroll patients prospectively and collect the requisite data for subsequent publication and larger grant opportunities. With the preliminary data we are able to obtain for this investigation, we intend to submit this project as an R01 NIH grant in the future. This grant has been invaluable in my career growth as a clinical and translational physician scientist and I am grateful for the Foundation’s continued unwavering support in allowing us to push our science to the next frontier.
Foundation of the ASNR Grant Program – Marios Georgiadis
Myelin, which insulates neuronal axons and makes up ~40% of our brain, is strongly involved in Alzheimer’s Disease, but its role is unclear, partly due to lack of methods to study it. Our novel myelin-specific imaging method using X-ray scattering can quantify myelin levels and integrity tomographically. With the generous support of the Foundation of the ASNR grant, I am leveraging this to quantify myelin degeneration in the Alzheimer’s brain, link it to molecular biomarkers, and translate it to quantitative in vivo MRI imaging. The FASNR grant is essential for this research that can yield new imaging and molecular biomarkers that can drive much-needed novel Alzheimer’s Disease diagnosis and treatment strategies.
Foundation of the ASNR Grant Program – Nancy Pham
Integrating functional MR perfusion biomarkers with genomic plasma EBV-DNA and 18FDG-PET/CT metabolic parameters can potentially improve tumor staging, prognostication, and surveillance beyond the traditional AJCC TNM staging system alone. The Foundation grant proved instrumental in my development as a clinician-scientist. It will support 12 months of dedicated research time, enabling me to collect crucial data for my research on NPC. This data has already directly contributed to my ability to secure additional grant funding. This early success strengthens my resolve to bridge the gap between clinical practice and scientific advancement
Foundation Donation Progress
We extend our heartfelt gratitude to our generous donors whose unwavering support has not only fueled our mission but also illuminated the path toward positive change in our community. Below is our progress, year to date.
Your support helps foster both scientific and clinical excellence and makes a difference in the lives of millions of patients under the care of neuroradiologists